Evidence map›Paper›PMID 33091332›Full record

ArticleBosnian journal of basic medical sciences2021

Development and validation of prognostic nomogram for lung cancer patients below the age of 45 years.

Lili Dai, Wei Wang, Qi Liu, Tongjia Xia, Qikui Wang, Qingqing Chen, Ning Zhu, Yu Cheng, Ying Yan, Jun Shu and 1 more

Abstract readValidation Study
In one paragraph

Article in Bosnian journal of basic medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lili DaiDepartment of Medicine, Funan County People's Hospital, Anhui, China.
Wei WangDepartment of Respiratory Medicine, Funan County People's Hospital, Anhui, China.
Qi LiuDepartment of Endocrinology, Punan Hospital of Pudong District, Shanghai, China.
Tongjia XiaDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Qikui WangDepartment of Chest Surgery, Anhui Chest Hospital, Anhui, China.
Qingqing ChenDepartment of Tuberculosis, Anhui Chest Hospital, Anhui, China.
Ning ZhuDepartment of Respiratory Medicine, The Second Affiliated Hospital of Xuzhou Medical University, Jiangsu China.
Yu ChengDepartment of Interventional Aulmonary and Endoscopy Center, Anhui Chest Hospital, Anhui, China.
Ying YanDepartment of Oncology, Anhui Cancer Hospital, Anhui, China.
Jun ShuDepartment of Respiratory Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Anhui, China.
Kaixin QuDepartment of Respiratory Medicine, Funan County People's Hospital, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to establish a nomogram for the prognostic prediction of patients with early-onset lung cancer (EOLC) in both overall survival (OS) and cancer-specific survival (CSS). EOLC patients diagnosed between 2004 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database and further divided into training and validation sets randomly. The prognostic nomogram for predicting 3-, 5- and 10-years OS and CSS was established based on the relative clinical variables determined by the multivariate Cox analysis results. Furthermore, the predictive performance of nomogram was assessed by concordance index (C-index), calibration curve, receiver operating characteristic (ROC) curve and decision curve analysis (DCA) curve. A total of 1,822 EOLC patients were selected and randomized into a training cohort (1,275, 70%) and a validation cohort (547, 30%). The nomograms were established based on the statistical results of Cox analysis. In training set, the C-indexes for OS and CSS prediction were 0.797 (95% confidence interval [CI]: 0.773-0.818) and 0.794 (95%CI:0.771-0.816). Significant agreement in the calibration curves was noticed in the nomogram models. The results of ROC and DCA indicated nomograms possessed better predict performance compared with TNM-stage and SEER-stage. And the area under the curve (AUC) of the nomogram for OS and CSS prediction in ROC analysis were 0.766 (95%CI:0.745-0.787) and 0.782 (95%CI:0.760-0.804) respectively. The prognostic nomogram provided an accurate prediction of 3-, 5-, and 10-year OS and CSS of EOLC patients which contributed clinicians to optimize individualized treatment plans.

Indexed as

NomogramsAdultAge of OnsetFemaleHumansLung NeoplasmsMalePredictive Value of TestsPrognosisSEER ProgramSurvival Rate

Identifiers

PMID33091332
PMCPMC8112561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.